Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d6cf4ac101eb4a233a4bc3799225e7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8222c8f11949a871f5866a548cc4a0f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea4bd7476e239949e34602e4c5ccaafc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_548b3e46672e5b4f0fed4673ae1df042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b77128a7ee02e7d62e25accd0df430b6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-624 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-802 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2011-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d598b30f116e88bbb80ce5fc3b77cff2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e7e3c04b763f3dae0aa9fd6a0d0d376 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e666f13222fab1651b5bf0d6eca8e50 |
publicationDate |
2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012321670-A1 |
titleOfInvention |
Formulations of nano-carriers and methods of preparing the same |
abstract |
A method of preparing nano-carriers is disclosed. The method includes mixing an organic solution of a drug and an organic solution of a biological agent separately with a predetermined amount of water having one or more dissolved surfactants to obtain a first mixture and a second mixture respectively. Subsequently, the first mixture and the second mixture are homogenized separately to obtain a solution of nano-crystals of the drug and a solution of nano-particles of the biological agent respectively. Thereafter, the solution of nano-crystals of the drug and the solution of nano-particles of the biological agent are together subjected to an ultra-sound homogenization to obtain a solution of nano-carriers. An interfacial extraction and/or a dialysis are then performed on the solution of nano-carriers to obtain the nano-carriers. Formulations of the nano-carriers are also disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016044482-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10596124-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707436-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114886855-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11260033-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111671982-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925149-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015057751-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10028919-B2 |
priorityDate |
2010-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |